These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804 [TBL] [Abstract][Full Text] [Related]
9. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059 [TBL] [Abstract][Full Text] [Related]
10. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura. Kosugi S; Matsumoto M; Ohtani Y; Take H; Ishizashi H; Fujimura Y; Kuyama J Int J Hematol; 2005 Jun; 81(5):433-6. PubMed ID: 16158827 [TBL] [Abstract][Full Text] [Related]
11. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092 [TBL] [Abstract][Full Text] [Related]
12. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Elliott MA; Heit JA; Pruthi RK; Gastineau DA; Winters JL; Hook CC Eur J Haematol; 2009 Oct; 83(4):365-72. PubMed ID: 19508684 [TBL] [Abstract][Full Text] [Related]
13. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment. Kameda T; Dobashi H; Kittaka K; Susaki K; Yamaoka G; Arai K; Tokuda M; Ishida T Clin Rheumatol; 2007 Dec; 26(12):2159-2162. PubMed ID: 17562094 [TBL] [Abstract][Full Text] [Related]
14. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. Rüfer A; Brodmann D; Gregor M; Kremer Hovinga JA; Lämmle B; Wuillemin WA Swiss Med Wkly; 2007 Sep; 137(37-38):518-24. PubMed ID: 17990141 [TBL] [Abstract][Full Text] [Related]
15. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor. Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057 [No Abstract] [Full Text] [Related]
16. [Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case]. Ojeda-Uribe M; Brunot A; Issler M Rev Med Chil; 2005 Nov; 133(11):1349-54. PubMed ID: 16446859 [TBL] [Abstract][Full Text] [Related]
17. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847 [TBL] [Abstract][Full Text] [Related]
18. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange]. Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471 [TBL] [Abstract][Full Text] [Related]
19. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687 [TBL] [Abstract][Full Text] [Related]
20. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Ling HT; Field JJ; Blinder MA Am J Hematol; 2009 Jul; 84(7):418-21. PubMed ID: 19507208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]